|
Current issue
Archive
Online First
About the journal
Editorial board
Abstracting and indexing
Subscription
Contact
Ethical standards and procedures
Special Issues
Instructions for authors
Publication charge
Editorial System
Submit your Manuscript
Open access 
|
1/2002
vol. 1 abstract:
Role of hormone replacement therapy in treatment of women with chronic renal failure – potential benefits and hazards
Beata Kos-Kudła
,
Bogdan Marek
,
Dariusz Kajdaniuk
,
Paweł Staszewicz
,
Zofia Ostrowska
(Prz Menopauz 2002; 1: 46–52)
Online publish date: 2004/03/03
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Patients with chronic renal failure (CRF) show an excess mortality from cardiovascular disease. In patients with CRF there have been identified many risk factors for cardiovascular diseases including estrogen deficiency which can manifest in women with CRF as premature menopause and it is associated with high risk not only for cardiovascular complications but for renal osteodystrophy as well. It is now well established that hormone replacement therapy (HRT) has beneficial effects on various atherosclerotic parameters in population of postmenopausal women and its role in primary prevention of coronary artery disease has been reported in many studies. There is still a question of debate if advanteges of HRT reported in studies based on general population of postmenopausal women can also be observed in women with CRF and estrogen deficiency.
keywords:
chronic renal failure, hormonal replacement therapy, estradiol, cardiovascular complications |
 |
